-
Exenatide, sold
under the
brand name
Byetta among others, is a
medication used to
treat type 2 diabetes. It is used
together with diet, exercise, and...
-
produced three drugs:
Symlin (pramlintide acetate),
Byetta (
exenatide) and
Bydureon (
exenatide extended release). In 1987,
Amylin Pharmaceuticals was co-founded...
- the
exception of insulin, most GLP-1
receptor agonists (liraglutide,
exenatide, and others), and pramlintide, all
diabetes medications are administered...
-
pancreatitis including metformin, but glucagon-like peptide-1
mimetics such as
exenatide are more
strongly ****ociated with
pancreatitis by
promoting inflammation...
-
version of exendin-4
called exenatide. In 2002, Eli
Lilly entered into an
alliance with
Amylin to
further develop exenatide and
secure official approval...
- injection.
Exenatide also
slows the
emptying of the
stomach and
causes a
decrease in appetite,
contributing to
weight loss. The
antidiabetic exenatide (Byetta)...
- the risk of thrombosis. It is an
antagonist of
glycoprotein IIb/IIIa.
Exenatide is a 39-amino-acid
peptide that is a
synthetic version of exendin-4, a...
- with
liraglutide 1.8 mg
compared to
insulin glargine, 0.33% more than
exenatide 10 μg
twice daily,
sitagliptin and rosiglitazone. In a
randomized controlled...
- S. Food and Drug
Administration (FDA) has
approved a
treatment called Exenatide,
based on the
saliva of a Gila monster, to
control blood sugar in patients...
- K+ATP GLP-1
receptor agonists Albiglutide‡ Danuglipron†
Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§
Semaglutide Taspoglutide† DPP-4...
